Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Related Articles by Review for PubMed (Select 9164315)

3.

The role of eptifibatide in patients undergoing percutaneous coronary intervention.

Zeymer U.

Expert Opin Pharmacother. 2007 Jun;8(8):1147-54. Review.

PMID:
17516878
4.

Clinical pharmacology of eptifibatide.

Phillips DR, Scarborough RM.

Am J Cardiol. 1997 Aug 18;80(4A):11B-20B. Review.

PMID:
9291241
5.

Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa.

O'Shea JC, Tcheng JE.

Expert Opin Pharmacother. 2002 Aug;3(8):1199-210. Review.

PMID:
12150697
8.
10.

Bleeding complications with new antithrombotics used in ischaemic heart disease.

Adgey AA.

Haemostasis. 1996 Sep-Oct;26(5):237-46. Review.

PMID:
8894654
11.

Clinical and economic studies of eptifibatide in coronary stenting.

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S.

Ther Clin Risk Manag. 2014 Aug 2;10:603-14. doi: 10.2147/TCRM.S35664. eCollection 2014. Review. Erratum in: Ther Clin Risk Manag. 2014;10:913.

12.

Hybrid coronary revascularization: an overview of options for anticoagulation and platelet inhibition.

Zimrin D, Bonatti J, Vesely MR, Lehr EJ.

Heart Surg Forum. 2010 Dec;13(6):E405-8. doi: 10.1532/HSF98.20101157. Review.

PMID:
21169155
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk